Regeneron Pharmaceuticals, Inc.
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
Last updated:
Abstract:
Radiolabeled anti-PD-L1 antibodies and their use in immuno-PET imaging are provided herein. Included are methods of detecting the presence of PD-L1 proteins in a patient or sample.
Status:
Grant
Type:
Utility
Filling date:
1 Dec 2017
Issue date:
11 Aug 2020